Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "DexCom Inc (DXCM) - Product Pipeline Analysis, 2025 Update" has been added to ResearchAndMarkets.com's offering. This analytical report serves as a ...
Shares of DexCom, Inc. ( DXCM) closed at a new 52-week high of $53.50 on Nov 10, translating into a solid one-year return of roughly 62%. In fact, shares of this CA-based glucose monitoring systems ...
DexCom projects 2025 revenue of $4.6 billion, representing 14% growth. This forecast assumes strong demand for CGM systems, expanded reimbursement coverage, and a second-half launch of a 15-day G7 ...
Dexcom DXCM announced its strategy to expand the accessibility of its glucose sensing technology products to millions of other patients than currently covered. Its plan includes expansion in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback